150 related articles for article (PubMed ID: 36884282)
1. Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention.
Carré A; Vecchio F; Flodström-Tullberg M; You S; Mallone R
Endocr Rev; 2023 Jul; 44(4):737-751. PubMed ID: 36884282
[TBL] [Abstract][Full Text] [Related]
2. [Coxsackievirus B infection and pathogenesis of type 1 diabetes].
Nekoua MP; Mercier A; Vergez I; Morvan C; Mbani CJ; Sane F; Lobert D; Engelmann I; Romond MB; Alidjinou EK; Hober D
Virologie (Montrouge); 2022 DéCembre 01; 26(6):415-430. PubMed ID: 36565260
[TBL] [Abstract][Full Text] [Related]
3. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine AB; Hytönen VP; Hyöty H; Flodström-Tullberg M
Diabetes; 2021 Dec; 70(12):2871-2878. PubMed ID: 34497136
[TBL] [Abstract][Full Text] [Related]
5. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus.
Nekoua MP; Alidjinou EK; Hober D
Nat Rev Endocrinol; 2022 Aug; 18(8):503-516. PubMed ID: 35650334
[TBL] [Abstract][Full Text] [Related]
6. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B Tailors the Unfolded Protein Response to Favour Viral Amplification in Pancreatic β Cells.
Colli ML; Paula FM; Marselli L; Marchetti P; Roivainen M; Eizirik DL; Op de Beeck A
J Innate Immun; 2019; 11(4):375-390. PubMed ID: 30799417
[TBL] [Abstract][Full Text] [Related]
8. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B.
Hyöty H; Leon F; Knip M
Expert Rev Vaccines; 2018 Dec; 17(12):1071-1083. PubMed ID: 30449209
[TBL] [Abstract][Full Text] [Related]
9. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
Stone VM; Hankaniemi MM; Svedin E; Sioofy-Khojine A; Oikarinen S; Hyöty H; Laitinen OH; Hytönen VP; Flodström-Tullberg M
Diabetologia; 2018 Feb; 61(2):476-481. PubMed ID: 29151123
[TBL] [Abstract][Full Text] [Related]
10. Replication Activities of Major 5' Terminally Deleted Group-B Coxsackievirus RNA Forms Decrease PCSK2 mRNA Expression Impairing Insulin Maturation in Pancreatic Beta Cells.
Callon D; Guedra A; Lebreil AL; Heng L; Bouland N; Fornès P; Berri F; Andreoletti L
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560784
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
[TBL] [Abstract][Full Text] [Related]
14. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
15. Combating coxsackievirus B infections.
Alhazmi A; Nekoua MP; Mercier A; Vergez I; Sane F; Alidjinou EK; Hober D
Rev Med Virol; 2023 Jan; 33(1):e2406. PubMed ID: 36371612
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses.
Vecchio F; Carré A; Korenkov D; Zhou Z; Apaolaza P; Tuomela S; Burgos-Morales O; Snowhite I; Perez-Hernandez J; Brandao B; Afonso G; Halliez C; Kaddis J; Kent SC; Nakayama M; Richardson SJ; Vinh J; Verdier Y; Laiho J; Scharfmann R; Solimena M; Marinicova Z; Bismuth E; Lucidarme N; Sanchez J; Bustamante C; Gomez P; Buus S; ; You S; Pugliese A; Hyoty H; Rodriguez-Calvo T; Flodstrom-Tullberg M; Mallone R
bioRxiv; 2023 Aug; ():. PubMed ID: 37662376
[TBL] [Abstract][Full Text] [Related]
17. Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin.
Ashton MP; Eugster A; Walther D; Daehling N; Riethausen S; Kuehn D; Klingel K; Beyerlein A; Zillmer S; Ziegler AG; Bonifacio E
Sci Rep; 2016 Sep; 6():32899. PubMed ID: 27604323
[TBL] [Abstract][Full Text] [Related]
18. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
Jaïdane H; Hober D
Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
[TBL] [Abstract][Full Text] [Related]
19. Diabetogenic potential of coxsackie B viruses in nature.
Jordan GW; Bolton V; Schmidt NJ
Arch Virol; 1985; 86(3-4):213-21. PubMed ID: 2998300
[TBL] [Abstract][Full Text] [Related]
20. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection.
Zanone MM; Favaro E; Ferioli E; Huang GC; Klein NJ; Perin PC; Peakman M; Conaldi PG; Camussi G
FASEB J; 2007 Oct; 21(12):3308-17. PubMed ID: 17494992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
